This fast-growing health and nutrition chain is opening a Bayshore and West Bend location
A health food chain that's added several suburban locations in the last five years is going to add two more.
Nona Nutrition, a nutrition and wellness store and eatery, will be opening a Bayshore and West Bend location later this year.
Owner Seth Knapp said Nona Nutrition was launched in 2018 "from a place of passion." He said it is "all things health and nutrition." Its first store opened in Pewaukee (at 1350 Capitol Drive) in 2019.
Since then, Nona has opened locations in Delafield (525 Main St.), Elm Grove (13320 Watertown Plank Road) and Mequon (1400 W. Mequon Road).
Knapp said the Bayshore location should open by the end of the summer or early fall and the West Bend location should open in the fall.
Knapp said the Bayshore location will be at 5800 N. Bayshore Drive in Glendale, across from the Nike Well Collective.
The West Bend location will be at the Sendik's Plaza, 280 N. 18th Ave., next to Planet Fitness.
Nona Nutrition has açaí smoothie bowls with many different add-ons including protein enhancers.
Other menu items are a Paradise Bowl (with a base of Brazilian açaí, dragon fruit, strawberries, and whey protein) and the Ultimate Green Bowl (with a base of Brazilian açaí, Organifi green juice superfood blend, blueberries, strawberries and whey protein).
Both include grain-free coconut cashew granola, banana slices, peanut butter, chia seeds, almond slices, toasted coconut flakes and raw honey toppings.
Nona Nutrition offers more than 10 different smoothies.
Options include lavender lemon blueberry (lavender, lemon omega, blueberries, banana, raw honey, superfood creamer and whey protein); pink dragon (dragon fruit, pineapple, banana, coconut cream, raw honey and banana whey protein) and green dream (spinach, banana, pineapple, mango nectar, coconut cream, raw honey and banana whey protein).
Nona Nutrition offers traditional coffee drinks such as lattes and cappuccinos, as well as specialty coffees including a maple lavender latte and a vanilla honeycomb latte.
For more information, visit nonanutrition.com or facebook.com/nonalakecountry.
Cathy Kozlowicz can be reached at 262-361-9132 or cathy.kozlowicz@jrn.com. Follow her on Twitter at @kozlowicz_cathy.
More: Indoor pickleball, a bakery and a gift shop are now open in Menomonee Falls and West Bend
More: McBrats and Teenie Beanies: West Bend woman reflects on 44 years at McDonald's
This article originally appeared on Milwaukee Journal Sentinel: Nona Nutrition to open locations at Bayshore and in West Bend in 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 hours ago
- Yahoo
UnitedHealth Group considers bids to divest Latin American unit
US health insurer UnitedHealth Group is considering multiple bids to offload its operations in Latin America, reported Reuters, citing sources. The insurer has been attempting to divest its Latin American assets since 2022, following losses exceeding $8bn in the region, the report said. The news agency further noted that the urgency to sell its subsidiary Banmedica, which operates in Colombia and Chile, has intensified in recent months due to financial pressures on multiple fronts. The company has already exited its operations in Brazil and Peru and is now focusing on securing a deal for its Colombian and Chilean operations. Currently, UnitedHealth has received four non-binding bids for Banmedica, estimated at around $1bn. The bidding entities are Acon Investments, Patria Investments, Christus Health and Auna from Lima. Auna is reportedly in discussions with a financial partner to strengthen its bid. UnitedHealth acquired Banmedica in 2018, with then-CEO David Wichmann expressing a long-term vision for growth in South America. However, the insurer decided to withdraw from the region three years later due to losses, particularly from its Brazilian operation, Amil. Despite Banmedica being profitable, with earnings before interest, taxes, depreciation and amortisation (EBITDA) of more than $200m, it is deemed too small for UnitedHealth's interests. Brazilian investment bank BTG Pactual is said to be advising UnitedHealth on the sale process. UnitedHealth expects to set a deadline for binding proposals for Banmedica by July, as it seeks to streamline its operations and focus on more profitable markets. The company bounced back to profitability in the first quarter of 2025, with net earnings of $6.4bn, compared with a net loss of $1.2bn in the same period a year ago. Stephen Hemsley took over the role of group CEO from Andrew Witty in May. "UnitedHealth Group considers bids to divest Latin American unit " was originally created and published by Life Insurance International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
21 hours ago
- Yahoo
UFC Fighter Ariane da Silva's Brain Tumor Made Weight Cut Impossible, Now Promotion May Cut Her After Third Consecutive Loss
UFC Fighter Ariane da Silva's Brain Tumor Made Weight Cut Impossible, Now Promotion May Cut Her After Third Consecutive Loss originally appeared on Athlon Sports. UFC fighters routinely push their bodies to dangerous extremes just to step on the scale—starving for weeks, sweating out water in saunas until they faint, and enduring kidney-straining dehydration protocols. The sport's weight-cutting culture forces athletes to gamble with their health, often walking the line between competition and hospitalization in pursuit of a size advantage. Advertisement These practices persist despite medical emergencies. Behind every weigh-in, there's often an untold story of suffering that does not get the spotlight as much as the knockout finishes and the trash talk. Dana WhiteGetty Images UFC flyweight Ariane da Silva's shocking six-pound weight miss ahead of her UFC 316 bout against Wang Cong was caused by complications from a benign pituitary tumor, her coach and husband Renato da Silva revealed during an interview with MMA Fighting. The Brazilian fighter, who tipped the scales at 132 pounds—well above the 126-pound non-title limit—underwent a dangerous weight cut attempt while managing hormonal imbalances triggered by the tumor. Advertisement Blood tests during her camp showed elevated prolactin and cortisol levels, leading to the discovery of the tumor, which disrupted her body's ability to shed weight safely. The situation worsened when da Silva's team enlisted a new nutritionist, whose strategy to retain water until the final days of the weight cut, backfired catastrophically. Renato described harrowing symptoms during the final push, including double vision, slurred speech, and loss of motor control—clear signs her body was shutting down. He emphasized that UFC medical staff intervened to halt the cut after deeming it life-threatening, saying, 'She wasn't walking right, blinking too slow, and couldn't focus.' Advertisement Her coach's decision to allow her to continue to fight despite these issues was baffling and was met with criticism by some people online. SportingNews journalist Val Dewar shared the interview on X (formerly Twitter), and expressed his opinion that 'Fighting with a tumor in your f— brain, even a benign one, seems like a bad Idea. Like, [a] really, really bad idea.' Her opponent Wang Cong was gracious enough to agree to a catchweight bout despite the weight disparity and accepted 30% of da Silva's purse. Wang also expressed sympathy on social media towards da Silva and her struggle trying to make weight, saying, 'After she came out, I went over to see her situation. Fortunately, there is no big problem, because it's not easy for every athlete.' Advertisement Da Silva ultimately lost a unanimous decision to Cong, extending her skid to three fights and putting her in the crosshairs of being cut from the promotion. The incident casts a spotlight on MMA's weight-cutting crisis, where fighters often gamble with extreme measures to hit weight targets before a fight. Da Silva's case is uniquely alarming due to the tumor's role, raising questions about whether she should have been cleared to fight at all. The UFC has yet to address if da Silva will receive medical suspension or specialized support moving forward. Related: UFC Champion Alexander Volkanovski Suffers Medical Scare During Fight 'I could not see' Related: UFC Coach Reveals He Nearly Pulled Out 'Half-Dead' Champion from Title Defense Due to Severe Medical Issues This story was originally reported by Athlon Sports on Jun 8, 2025, where it first appeared.
Yahoo
2 days ago
- Yahoo
Exclusive-UnitedHealth eyes $1 billion deal to exit Latin America as insurer refocuses on US, sources say
By Tatiana Bautzer and Sabrina Valle NEW YORK (Reuters) -UnitedHealth Group is weighing multiple bids for its Latin American operations, according to two people with direct knowledge of the matter, as the insurer buckles down after a series of unprecedented missteps that include the ouster of its CEO and a reported criminal accounting probe. The largest U.S. health insurer has been trying to exit Latin America since 2022, but the sale of Banmedica has taken on increasing urgency in recent months as the insurer took hits on multiple fronts, according to one of the people. New CEO Steve Hemsley told shareholders last week that he was determined to earn back their trust after an earnings miss and a Wall Street Journal report that the company was under criminal investigation for alleged Medicare fraud. UnitedHealth has said it was not notified by the Department of Justice and that it stands by the integrity of its operations. Hemsley replaced Andrew Witty as CEO, who had been in the post for only a matter of months following the murder of his predecessor, Brian Thompson, in New York in December while on his way to a meeting with investors. The company has four non-binding bids for its Banmedica subsidiary, which operates in Colombia and Chile, for about $1 billion, according to both people, who asked not to be identified because the talks are private. UnitedHealth's shares tumbled 25.5% in May alone and year-to-date are down 40%. UnitedHealth left Brazil in 2023 and Peru in March. It's aiming to get around $1 billion for Banmedica's operations in Colombia and Chile, the people said. The two people said the company expects to set a deadline for binding proposals as soon as July. UnitedHealth received bids from Washington, D.C.-based private equity firm Acon Investments; Sao Paulo-based private equity firm Patria Investments; Texas non-profit health firm Christus Health; and Lima-based healthcare and insurance provider Auna, the people said. Auna is in talks with a financial partner, one of the sources added. Banmedica's annual earnings before income taxes, depreciation and amortization, or EBITDA, is more than $200 million a year. Patria and Christus Health declined to comment. UnitedHealth, Acon and Auna did not respond to requests for comment. FAILED EXPANSION PLANS UnitedHealth bought Banmedica in 2018, with CEO David Scott saying he was "establishing a foundation for growth in South America for the next decades." At the time, UnitedHealth paid around 12 times Banmedica's EBITDA, according to one of the people. Three years later, the insurer decided to leave Latin America as it grappled with losses in its largest operation in the region, Brazil's Amil, which had been acquired a decade earlier. It divested from its Brazilian operations in late 2023. Banmedica is currently profitable, but is considered too small by UnitedHealth. It serves over 2.1 million consumers through its health insurance programs and has around 4 million patient visits annually across its network of 13 hospitals and 143 medical centers. UnitedHealth booked an $8.3 billion loss last year related to the sale of its South American operations - $7.1 billion stemming from the Brazil exit and $1.2 billion from Banmedica. "These losses relate to our strategic exit of South American markets and include significant losses related to foreign currency translation effects," the company said in a February filing. Brazilian investment bank BTG Pactual is advising UnitedHealth on the sale.
